Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) EV/EBIT Ratio: 24.28x

Is Hologic, Inc.’s EV/EBIT ratio high or low?

Hologic, Inc.'s EV/EBIT ratio of 24.28x is 33% above its 5-year average of 18.32x, around the middle of its 5-year range (7.08x–33.56x).

The EV/EBIT ratio for Hologic, Inc. (HOLX) is 24.28x as of Wednesday, June 10, 2026. It is above its 12-month average by 7.17% (22.66x).

HOLX EV/EBIT Ratio Chart

HOLX EV/EBIT Ratio
24.28x+53.48% 1Y
Zoom

HOLX Average EV/EBIT Ratio Chart

HOLX Current vs Average EV/EBIT Ratio Chart

HOLX EV/EBIT Ratio Metrics

EV/EBIT RATIO

24.28x

EV/EBIT RATIO AVG TTM

22.66x

EV/EBIT RATIO AVG 3Y

24.05x

EV/EBIT RATIO AVG 5Y

18.32x

EV/EBIT RATIO AVG 10Y

61.10x

EV/EBIT RATIO AVG 15Y

57.23x

EV/EBIT RATIO AVG 20Y

53.86x

CURRENT VS TTM AVG

+7.17%

CURRENT VS 3Y AVG

+0.94%

CURRENT VS 5Y AVG

+32.53%

CURRENT VS 10Y AVG

-60.26%

CURRENT VS 15Y AVG

-57.58%

CURRENT VS 20Y AVG

-54.92%

HOLX Competitors' EV/EBIT Ratio

NAMEMARKET CAPEV/EBIT RATIOTTM3Y5Y
Hologic, Inc. (HOLX)$16.97B24.28x22.66x24.05x18.32x
Moderna, Inc. (MRNA)$18.40BN/A23.08x30.94x30.94x
Align Technology, Inc. (ALGN)$12.56B19.62x19.31x26.46x31.52x
BioNTech SE (BNTX)$21.81BN/A4.91x5.85x5.85x
Mettler-Toledo International Inc. (MTD)$22.85B21.94x26.09x26.29x29.26x
Baxter International Inc. (BAX)$10.49BN/A442.63x243.35x134.31x
Waters Corporation (WAT)$23.83B54.60x27.55x26.51x26.24x
Charles River Laboratories International, Inc. (CRL)$9.06B25.46x62.90x38.55x35.16x
Bio-Rad Laboratories, Inc. (BIO)$7.89B36.51x38.03x32.82x33.28x
Veeva Systems Inc. (VEEV)$26.73B26.56x45.54x60.66x66.33x

Hologic, Inc. EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Hologic, Inc. EV/EBIT Ratio FAQ

What is the EV/EBIT ratio for Hologic, Inc. (HOLX)?
The EV/EBIT ratio for HOLX stock is 24.28x.
Is Hologic, Inc.'s EV/EBIT ratio high or low?
Hologic, Inc.'s EV/EBIT ratio of 24.28x is 33% above its 5-year average of 18.32x, around the middle of its 5-year range (7.08x–33.56x).
What is the TTM average EV/EBIT ratio for Hologic, Inc. (HOLX)?
The TTM average EV/EBIT ratio for HOLX stock is 22.66x.
What is the 3Y average EV/EBIT ratio for Hologic, Inc. (HOLX)?
The 3Y average EV/EBIT ratio for HOLX stock is 24.05x.
What is the 5Y average EV/EBIT ratio for Hologic, Inc. (HOLX)?
The 5Y average EV/EBIT ratio for HOLX stock is 18.32x.
What is the 10Y average EV/EBIT ratio for Hologic, Inc. (HOLX)?
The 10Y average EV/EBIT ratio for HOLX stock is 61.10x.
What is the 15Y average EV/EBIT ratio for Hologic, Inc. (HOLX)?
The 15Y average EV/EBIT ratio for HOLX stock is 57.23x.
What is the 20Y average EV/EBIT ratio for Hologic, Inc. (HOLX)?
The 20Y average EV/EBIT ratio for HOLX stock is 53.86x.

Hologic, Inc. EV/EBIT Ratio History

DATEEV/EBIT RATIO
2026-04-0724.28x
2026-04-0624.28x
2026-04-0224.17x
2026-04-0124.15x
2026-03-3124.15x
2026-03-3024.14x
2026-03-2724.17x
2026-03-2624.18x
2026-03-2524.13x
2026-03-2424.14x
2026-03-2324.17x
2026-03-2024.09x
2026-03-1924.07x
2026-03-1824.01x
2026-03-1723.98x
2026-03-1624.01x
2026-03-1324.00x
2026-03-1224.03x
2026-03-1124.09x
2026-03-1024.13x
2026-03-0924.15x
2026-03-0624.20x
2026-03-0524.20x
2026-03-0424.17x
2026-03-0324.11x
2026-03-0224.11x
2026-02-2724.08x
2026-02-2624.04x
2026-02-2524.07x
2026-02-2424.07x
2026-02-2324.10x
2026-02-2024.10x
2026-02-1924.01x
2026-02-1824.03x
2026-02-1724.01x
2026-02-1323.98x
2026-02-1223.94x
2026-02-1123.99x
2026-02-1024.01x
2026-02-0923.97x
2026-02-0623.91x
2026-02-0523.87x
2026-02-0423.84x
2026-02-0323.85x
2026-02-0223.88x
2026-01-3023.94x
2026-01-2923.96x
2026-01-2824.66x
2026-01-2724.70x
2026-01-2624.69x
2026-01-2324.65x
2026-01-2224.67x
2026-01-2124.68x
2026-01-2024.67x
2026-01-1624.63x
2026-01-1524.64x
2026-01-1424.68x
2026-01-1324.59x
2026-01-1224.59x
2026-01-0924.59x
2026-01-0824.59x
2026-01-0724.62x
2026-01-0624.60x
2026-01-0524.55x
2026-01-0224.49x
2025-12-3124.47x
2025-12-3024.49x
2025-12-2924.48x
2025-12-2624.47x
2025-12-2424.47x
2025-12-2324.59x
2025-12-2224.60x
2025-12-1924.62x
2025-12-1824.61x
2025-12-1724.61x
2025-12-1624.64x
2025-12-1524.69x
2025-12-1224.63x
2025-12-1124.58x
2025-12-1024.58x
2025-12-0924.60x
2025-12-0824.58x
2025-12-0524.62x
2025-12-0424.59x
2025-12-0324.64x
2025-12-0224.58x
2025-12-0124.58x
2025-11-2824.62x
2025-11-2624.57x
2025-11-2524.59x
2025-11-2424.56x
2025-11-2124.43x
2025-11-2024.35x
2025-11-1924.37x
2025-11-1824.35x
2025-11-1724.74x
2025-11-1424.75x
2025-11-1324.78x
2025-11-1224.88x
2025-11-1124.89x
2025-11-1024.79x
2025-11-0724.73x
2025-11-0624.75x
2025-11-0524.77x
2025-11-0424.73x
2025-11-0324.72x
2025-10-3124.67x
2025-10-3024.68x
2025-10-2924.69x
2025-10-2824.70x
2025-10-2724.68x
2025-10-2424.69x
2025-10-2324.66x
2025-10-2224.68x
2025-10-2124.69x
2025-10-2024.02x
2025-10-1723.38x
2025-10-1622.95x
2025-10-1522.47x
2025-10-1422.12x
2025-10-1321.99x
2025-10-1022.71x
2025-10-0922.98x
2025-10-0822.89x
2025-10-0722.70x
2025-10-0622.58x
2025-10-0322.86x
2025-10-0222.76x
2025-10-0122.48x
2025-09-3022.62x
2025-09-2922.51x
2025-09-2622.53x
2025-09-2522.08x
2025-09-2422.28x
2025-09-2322.67x
2025-09-2222.56x
2025-09-1922.25x
2025-09-1822.87x
2025-09-1722.85x
2025-09-1621.30x
2025-09-1521.45x
2025-09-1221.65x
2025-09-1122.27x
2025-09-1021.99x
2025-09-0922.38x
2025-09-0822.32x
2025-09-0522.39x
2025-09-0422.27x
2025-09-0322.22x
2025-09-0222.34x
2025-08-2922.51x
2025-08-2822.35x
2025-08-2722.38x
2025-08-2622.35x
2025-08-2522.51x
2025-08-2222.87x
2025-08-2122.52x
2025-08-2023.03x
2025-08-1922.73x
2025-08-1822.55x
2025-08-1522.73x
2025-08-1422.80x
2025-08-1323.10x
2025-08-1222.77x
2025-08-1122.78x
2025-08-0822.80x
2025-08-0722.76x
2025-08-0622.43x
2025-08-0522.73x
2025-08-0422.76x
2025-08-0122.52x
2025-07-3122.41x
2025-07-3022.64x
2025-07-2922.98x
2025-07-2822.87x
2025-07-2523.13x
2025-07-2423.00x
2025-07-2322.95x
2025-07-2222.76x
2025-07-2122.22x
2025-07-1822.31x
2025-07-1722.32x
2025-07-1622.27x
2025-07-1522.08x
2025-07-1422.52x
2025-07-1122.88x
2025-07-1023.24x
2025-07-0922.92x
2025-07-0822.61x
2025-07-0722.44x
2025-07-0322.57x
2025-07-0222.74x
2025-07-0122.75x
2025-06-3022.69x
2025-06-2722.65x
2025-06-2622.68x
2025-06-2522.41x
2025-06-2422.59x
2025-06-2322.46x
2025-06-2022.47x
2025-06-1822.31x
2025-06-1722.36x
2025-06-1622.70x
2025-06-1322.56x
2025-06-1222.71x
2025-06-1122.51x
2025-06-1022.69x
2025-06-0922.50x
2025-06-0622.42x
2025-06-0522.02x
2025-06-0421.85x
2025-06-0322.01x
2025-06-0221.67x
2025-05-3021.72x
2025-05-2921.97x
2025-05-2822.22x
2025-05-2721.72x
2025-05-2319.17x
2025-05-2219.23x
2025-05-2119.34x
2025-05-2019.88x
2025-05-1919.86x
2025-05-1619.98x
2025-05-1519.64x
2025-05-1419.52x
2025-05-1320.09x
2025-05-1220.64x
2025-05-0919.97x
2025-05-0819.78x
2025-05-0719.54x
2025-05-0618.79x
2025-05-0518.67x
2025-05-0219.13x
2025-05-0114.84x
2025-04-3015.06x
2025-04-2915.10x
2025-04-2815.03x
2025-04-2515.02x
2025-04-2415.09x
2025-04-2315.05x
2025-04-2215.06x
2025-04-2114.76x
2025-04-1714.91x
2025-04-1614.65x
2025-04-1514.98x
2025-04-1415.22x
2025-04-1114.98x
2025-04-1014.81x
2025-04-0915.34x
2025-04-0815.13x
2025-04-0715.82x
2025-04-0415.72x
2025-04-0315.92x
2025-04-0215.64x
2025-04-0115.84x
2025-03-3115.94x
2025-03-2815.83x
2025-03-2716.07x
2025-03-2615.87x
2025-03-2515.70x

Showing the most recent 260 of 4,030 data points. The chart above shows the full history.

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini